On the Record · Moderna
Moderna acquisitions, on the record
The businesses Moderna bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
OriCiro Genomics K.K.Word for word“In January 2023, we acquired OriCiro Genomics K.K., a Japan-based, privately held biotech company primarily focused on cell-free DNA synthesis and amplification technologies, for $86 million.” 10-K for 2023 | acquisition | January 2023 | $86 million |
newly constructed 140,000 square feet biomanufacturing facility in Marlborough, MassachusettsWord for word“In the second quarter of 2023, we acquired a newly constructed, 140,000 square feet biomanufacturing facility in Marlborough, Massachusetts.” 10-K for 2023 | acquisition | In the second quarter of 2023 | — |
Business not named in the filing (cash flow statement line 'Acquisition of business, net of cash acquired')Word for word“Acquisition of business, net of cash acquired — ( 85 ) — ” 10-K for 2024 | acquisition | — | ( 85 ) |
biomanufacturing facility in Marlborough, MassachusettsWord for word“In the second quarter of 2023, we acquired a biomanufacturing facility in Marlborough, Massachusetts.” 10-K for 2025 | acquisition | In the second quarter of 2023 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) |
|---|---|
| 2021-12-31 | $0 |
| 2022-12-31 | $0 |
| 2023-12-31 | $85 million |
| 2024-12-31 | $0 |
| 2025-12-31 | $0 |
Deal filings since 2016
- 2026-09-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2026-03-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-11-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-08-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-07-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-05-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-04-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-02-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-05-08 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Moderna’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.